1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsCOiMMUNITY Initiative is sponsored by GlaxoSmithKline (GSK). GSK's COiMMUNITY Initiative offers grants to organizations aiming to improve vaccine education and access across the U. S.
Get alerted about grants like this
Get emailed when new opportunities from “GlaxoSmithKline (GSK)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025 | GSK US For media and investors only GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025 GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education, outreach and access These grants are part of GSK’s COiMMUNITY Initiative, which aims to address adult immunization barriers through funding, increased data transparency and resource-sharing opportunities The call for new COiMMUNITY Initiative grant proposals is now open GSK plc (LSE/NYSE: GSK) today announced the recipients of its COiMMUNITY Initiative grant program, awarding nearly $2 million to 15 regional, state and national non-profits and community-based groups working to boost adult immunization through improved vaccine education, outreach and access.
Leonard Friedland, VP and Director, Scientific Affairs and Public Health, Vaccines, GSK, said: “We are committed to ensuring people have access to clear, trustworthy information about vaccines so that they can make the best decisions for themselves and their families. The 2024 COiMMUNITY Initiative grant recipients have designed vaccine education, outreach and access programs with the needs of their specific communities in mind.
By offering educational tools to individuals and healthcare providers, these organizations are empowering people to take control of their preventive health and make informed choices about vaccination.
” The 2024 COiMMUNITY Initiative grant recipients include Sepsis Alliance and Pennsylvania Pharmacists Association who complement one another’s efforts by approaching adult immunization gaps from different angles — from making the connection between vaccines and the prevention of a little-known but deadly illness to helping pharmacists make vaccination a year-round effort.
“Adult immunization rates tend to rise and fall with the seasons, even though most vaccines are not inherently seasonal. With GSK’s support, we are equipping pharmacies across the Commonwealth with the tools they need to encourage year-round vaccination so that we don't miss out on opportunities for protection, said Victoria Elliott, CEO, Pennsylvania Pharmacists Association (PPA).
PPA’s COiMMUNITY grant efforts include education to assist in targeted year-round outreach and technology to identify eligible recipients and help track vaccinations.
” Other awardees for 2024 are American Heart Association, American Lung Association, American Pharmacists Association, Asthma and Allergy Foundation of America, Autism Society, Ever Thrive Illinois, Global Healthy Living Foundation, Indiana Immunization Coalition, National Council on Aging, National Foundation for Infectious Diseases, Pharmacy Society of Wisconsin, Ryan Health and The Immunization Partnership.
Call for 2025 COiMMUNITY Initiative Grant Proposals This year, GSK will be awarding another $2 million in COiMMUNITY Initiative grants to support ambitious and actionable efforts to increase US adult immunization rates through vaccine education, outreach and access. Eligible organizations can submit a proposal through gskgrants. com.
Please address your letter of request to the COiMMUNITY Initiative. GSK will review grant proposals on a rolling basis until mid-November of 2025. GSK’s COiMMUNITY Initiative aims to address long-standing barriers to adult immunization in the US through funding, increased data transparency and resource-sharing opportunities.
Since the start of the COiMMUNITY Initiative grant program in 2023, GSK has awarded a total of $3 million to regional, state and national non-profits and community-based groups working to build awareness and access to adult vaccination across the US. GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.
com. Cautionary statement regarding forward-looking statements GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.
D “Risk factors” in GSK’s Annual Report on Form 20-F for 2024. Contact our GSK US Media Team. We are committed to responding to the information needs of the media as quickly as possible We unite science, technology and talent to get ahead of disease together Keep up to date with our news and recent announcements
According to the current listing, eligibility includes: Non-profit organizations, community-based groups, and public health entities in the U. S. Confirm the full requirements in the official notice before applying.
The current listing shows up to $3,000,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
COiMMUNITY Initiative is funded by GlaxoSmithKline (GSK). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.